Daniel Grosslight
Stock Analyst at Citigroup
(1.16)
# 3,764
Out of 5,124 analysts
114
Total ratings
33.8%
Success rate
-13.95%
Average return
Main Sectors:
Stocks Rated by Daniel Grosslight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAY Waystar Holding | Maintains: Buy | $49 → $46 | $24.30 | +89.30% | 3 | Jan 9, 2026 | |
| TDOC Teladoc Health | Maintains: Neutral | $10 → $9 | $5.01 | +79.64% | 13 | Jan 9, 2026 | |
| PHR Phreesia | Maintains: Buy | $29 → $25 | $12.20 | +104.92% | 8 | Jan 9, 2026 | |
| HCAT Health Catalyst | Maintains: Neutral | $3.25 → $2.75 | $2.15 | +27.91% | 12 | Jan 9, 2026 | |
| GDRX GoodRx Holdings | Maintains: Buy | $5 → $4.5 | $2.44 | +84.43% | 8 | Jan 9, 2026 | |
| EVH Evolent Health | Maintains: Buy | $9.5 → $6 | $2.85 | +110.53% | 6 | Jan 9, 2026 | |
| CTEV Claritev | Maintains: Buy | $80 → $63 | $25.91 | +143.15% | 4 | Jan 9, 2026 | |
| ACH Accendra Health | Maintains: Buy | $7 → $4 | $2.39 | +67.36% | 1 | Jan 9, 2026 | |
| CAH Cardinal Health | Upgrades: Buy | $190 → $244 | $226.32 | +7.81% | 11 | Jan 9, 2026 | |
| MCK McKesson | Maintains: Buy | $820 → $860 | $948.68 | -9.35% | 8 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $3 → $1 | $0.65 | +54.32% | 6 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $25 → $30 | $23.02 | +30.32% | 11 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $21.99 | +13.69% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $10 | $2.22 | +350.45% | 7 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $7 → $8 | $8.95 | -10.61% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1.25 | $1.10 | +13.64% | 5 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7 → $3.5 | $3.88 | -9.79% | 2 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $10.65 | +22.07% | 1 | Dec 11, 2019 |
Waystar Holding
Jan 9, 2026
Maintains: Buy
Price Target: $49 → $46
Current: $24.30
Upside: +89.30%
Teladoc Health
Jan 9, 2026
Maintains: Neutral
Price Target: $10 → $9
Current: $5.01
Upside: +79.64%
Phreesia
Jan 9, 2026
Maintains: Buy
Price Target: $29 → $25
Current: $12.20
Upside: +104.92%
Health Catalyst
Jan 9, 2026
Maintains: Neutral
Price Target: $3.25 → $2.75
Current: $2.15
Upside: +27.91%
GoodRx Holdings
Jan 9, 2026
Maintains: Buy
Price Target: $5 → $4.5
Current: $2.44
Upside: +84.43%
Evolent Health
Jan 9, 2026
Maintains: Buy
Price Target: $9.5 → $6
Current: $2.85
Upside: +110.53%
Claritev
Jan 9, 2026
Maintains: Buy
Price Target: $80 → $63
Current: $25.91
Upside: +143.15%
Accendra Health
Jan 9, 2026
Maintains: Buy
Price Target: $7 → $4
Current: $2.39
Upside: +67.36%
Cardinal Health
Jan 9, 2026
Upgrades: Buy
Price Target: $190 → $244
Current: $226.32
Upside: +7.81%
McKesson
Sep 24, 2025
Maintains: Buy
Price Target: $820 → $860
Current: $948.68
Upside: -9.35%
Aug 6, 2025
Downgrades: Neutral
Price Target: $3 → $1
Current: $0.65
Upside: +54.32%
May 6, 2025
Maintains: Sell
Price Target: $25 → $30
Current: $23.02
Upside: +30.32%
Apr 22, 2024
Initiates: Buy
Price Target: $25
Current: $21.99
Upside: +13.69%
Aug 9, 2023
Maintains: Neutral
Price Target: $9 → $10
Current: $2.22
Upside: +350.45%
Aug 4, 2023
Downgrades: Sell
Price Target: $7 → $8
Current: $8.95
Upside: -10.61%
Apr 28, 2023
Maintains: Neutral
Price Target: $1.5 → $1.25
Current: $1.10
Upside: +13.64%
Nov 16, 2021
Downgrades: Neutral
Price Target: $7 → $3.5
Current: $3.88
Upside: -9.79%
Dec 11, 2019
Initiates: Outperform
Price Target: $13
Current: $10.65
Upside: +22.07%